Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Agilent
Acquired Company
Proscia
Santa ClaraPhiladelphiaBiotechnologyInformation TechnologySoftwareDescription
Agilent announced its acquisition of Proscia for $240 million, including potential milestones of up to $30 million. This deal will allow Agilent to gain control over technology that connects various components of the pathology workflow. The acquisition signifies Agilent's commitment to advancing its digital pathology capabilities.
Fundz sees it the moment Agilent makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Proscia?
Proscia was acquired by Agilent, based in Santa Clara. The deal was reported on October 14, 2026. Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent is privately held and operates in Biotechnology.
When did Agilent acquire Proscia?
Agilent's acquisition of Proscia was reported on October 14, 2026. Agilent announced its acquisition of Proscia for $240 million, including potential milestones of up to $30 million. This deal will allow Agilent to gain control over technology that connects various components of the pathology workflow. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Proscia do?
Proscia is a software company accelerating pathology’s transition to a digital, data-driven discipline and enabling AI to advance precision medicine. It is privately held, operating in Information Technology, and is based in Philadelphia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.